Cite
HARVARD Citation
Genovese, M. et al. (n.d.). FRI0227 Five-Year Safety and Efficacy of Subcutaneous Abatacept in Patients with Moderate To Severely Active RA and An Inadequate Response To MTX: Long-Term Extension of The Phase III, Double-Blind, Randomized Acquire Study. Annals of the rheumatic diseases. p. 515. [Online].